Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14
If you're working with research-grade peptides, treat reconstitution as a precision protocol, not a rough guideline
Selected studies BPC-157 and growth hormone receptor expression in tendon fibroblasts (Molecules, 2014) PubMed | PMID 25415472 BPC-157 and angiogenesis in muscle and tendon healing research (J Physiol Pharmacol, 2009) PubMed | PMID 20388964 BPC-157 and the Src-Caveolin-1-eNOS vasomotor pathway research (Sci Rep, 2020) PubMed | PMID 33051481 BPC-157 and gastric ulcer research in rats (World J Gastroenterol, 2004) PubMed | PMID 15052688 Browse all BPC-157 research on PubMed PubMed Literature Search Cited literature is provided for scientific reference only
:max_bytes(150000):strip_icc()/VWH-GettyImages-2276706586.jpg-4e49ad1f948143ed99767b89bf0289d7.jpg)
Safe for Blood Sugar and Hormonal Balance AOD 9604, unlike full HGH treatments, does not affect blood sugar levels or IGF-1 (insulin-like growth factor) which are important considerations for people with diabetes or hormonal imbalance
A real discovery in recent years is a peptide called BPC-157
Safety Profile and Considerations BPC-157 demonstrates a remarkably benign safety profile in preclinical research
